This document discusses a panel discussion on commercializing space-based research and development and manufacturing. The panelists included the president of a company called iXpressGenes, an associate director from the National Center for Advancing Translational Sciences, and the president of Made In Space. The panel, moderated by a writer from Fast Company, focused on using the microgravity environment of low Earth orbit to conduct protein crystal growth for drug development, perform tissue-on-chip experiments to study human disease, and develop advanced manufacturing techniques. The goal is to utilize the International Space Station and find sustainable business opportunities to further space commercialization and translation.